Format

Send to

Choose Destination
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:203-8. doi: 10.1016/j.ejogrb.2016.04.005. Epub 2016 Apr 12.

Maternal obesity in Europe: where do we stand and how to move forward?: A scientific paper commissioned by the European Board and College of Obstetrics and Gynaecology (EBCOG).

Author information

1
Department of Development and Regeneration, KU Leuven, University of Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals KU Leuven, Leuven, Belgium; Department of Obstetrics, Gynecology and Fertility, GZA Sint-Augustinus, Wilrijk, Belgium. Electronic address: roland.devlieger@uzleuven.be.
2
Department of Endocrinology, UZ Gasthuisberg, KU Leuven, Belgium.
3
Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, The Clinical Institute of Medicine, Faculty of Health and Medicine Sciences, University of Copenhagen, Denmark.
4
Department of Development and Regeneration, KU Leuven, University of Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals KU Leuven, Leuven, Belgium.
5
Department of Obstetrics & Gynecology, Victoria Hospital, Kirkcaldy, Scotland, UK.
6
Endocrinology School of Medicine and Galway Diabetes Research Centre (GDRC), National University of Ireland, Galway (NUIG), Ireland.
7
Department of Development and Regeneration, KU Leuven, University of Leuven, Leuven, Belgium; Faculty of Health and Social Work, Research Unit Healthy Living, UC Leuven-Limburg, Belgium; Faculty of Medicine and Health Sciences, Centre for Research and Innovation in Care (CRIC), University of Antwerp, Belgium.

Abstract

Paralleling the global epidemic of obesity figures in the general population, the incidence of maternal obesity (BMI>30kg/m(2) at the start of pregnancy) has been rising over the last world. While most European countries do not systematically report obesity figures in their pregnant population, the prevalence of maternal obesity varies from 7 to 25% and seems strongly related to social and educational inequalities. Obesity during pregnancy represents an important preventable risk factor for adverse pregnancy outcomes and is associated with negative long-term health outcomes for both mothers and offspring. These effects are often aggravated by the high incidence of abnormal glucose tolerance and excessive gestational weight gain found in this group. The main controversies around the management of the obese pregnant women are related to (1) the value of repeated weighing during pregnancy, (2) the optimal gestational weight gain to advise and the lifestyle messages to deliver in order to achieve this, (3) the optimal strategy and timing of screening for gestational diabetes (GDM) and (4) the optimal timing and mode of delivery. These controversies are reviewed in this review, with the exception of screening for gestational diabetes that is discussed extensively elsewhere in this issue (Benhalima et al.). An agenda for research is proposed with the hope that it will catch the attention of policy-makers and funders and ultimately lead to the development of European-wide evidence-based guidelines for clinicians.

KEYWORDS:

EBCOG; Epidemiology; Europe; Maternal obesity; Preconception; Prevention

PMID:
27160501
DOI:
10.1016/j.ejogrb.2016.04.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center